Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06117280
Other study ID # 20329
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 18, 2023
Est. completion date October 20, 2023

Study information

Verified date November 2023
Source Iovate Health Sciences International Inc
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Research has shown that acute ingestion of Paraxanthine (1,7-dimethylxanthine, PXN) can enhance various markers of focus, including memory, reaction time, and attention in healthy adults. To assess these effects, this placebo-controlled crossover trial will compare the effects of 200 and 300mg of PXN to a placebo control. Participants will abstain from caffeine for 3 days, before taking the first test/placebo product for 3 consecutive days. Participants will complete questionnaires at 30, 60, 90, and 120 minutes after ingestion on Day 1 and Day 3 of ingestion. Participants will have a 3-day washout period before trialing the next test product/placebo.


Description:

Following enrollment to the study, participants will abstain from any products containing caffeine, for 3 days. On the night of the 3rd day of caffeine abstinence, participants will fast overnight (~10 hours) The morning after the fast, participants will complete the Day 1 baseline questionnaire. Participants will then consume Test Product A and complete questionnaires 30, 60, 90, and 120 minutes after ingestion. Test Products should be consumed in a fasted state, and 1-hour post-ingestion participants will consume a standardized meal (See Section 6.3). On Day 2, participants will consume Test Product A again but will not complete any questionnaires. The product should be consumed in a fasted state and participants will consume the standardized meal 60 minutes post-ingestion. On Day 3, participants will consume Test Product A in a fasted state and will again consume the standardized meal 1-hour following ingestion of the product. Participants will complete questionnaires 30, 60, 90, and 120 minutes after ingestion. Participants will then have a 3-day washout period with no products consumed or questionnaires completed. Following the washout period, the intervention cycle will be repeated with Test Product B and, subsequently, Test Product C. The questionnaires will consist of study-specific surveys and a cognitive assessment battery.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date October 20, 2023
Est. primary completion date October 18, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Aged between 18-35 - Willing to abstain from caffeine-containing beverages and foods during the duration of the study - Recreationally active; currently performing structured exercise (e.g., running, weightlifting, team-sport activity) at least 2 days per week for the previous 3 months Exclusion Criteria: - Body Mass Index: >29.9kg/m2 - Inability to adhere to protocol guidelines (e.g., caffeine, alcohol, tobacco) - Regular tobacco use - Illicit drug use (e.g., growth hormone, testosterone, etc.) - A diagnosed medical condition under the care of a physician (e.g. type 2 diabetes) Inability to abstain from supplements (e.g. protein, creatine, HMB, BCAA, phosphatidic acid, etc.) at least three weeks before the trial - Individuals on medications known to affect caffeine metabolism (e.g., corticosteroids, non-steroidal anti-inflammatories, or prescription-strength acne medications) - Participants who are amenorrheic (females only) - Inability to comply with the study protocol as judged by the investigators

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Paraxanthine 200 mg
For the three-day test cycle, participants will take one capsule per day amounting to 200mg of paraxanthine.
Paraxanthine 300 mg
For the three-day test cycle, participants will take one capsule per day amounting to 300mg of paraxanthine.
Placebo
The placebo will contain resistant dextrin. For the three-day test cycle, participants will take one capsule per day amounting to 300mg of resistant dextrin.

Locations

Country Name City State
United States Citruslabs Santa Monica California

Sponsors (2)

Lead Sponsor Collaborator
Iovate Health Sciences International Inc Citruslabs

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in scores on a cognitive assessment "Double Trouble". [Time Frame: Baseline to Day 3 of each test cycle] Participants will independently complete a cognitive assessment battery at home on their computer or tablet. "Double Trouble" is a 90-second timed test. Based on a classic Stroop test, Double Trouble measures selective attention, processing speed, and the brain's ability to focus on specific information when presented with conflicting and layered stimuli. 18 days
Primary Changes in scores on a cognitive assessment "Feature Match". [Time Frame: Baseline to Day 3 of each test cycle] Participants will independently complete a cognitive assessment battery at home on their computer or tablet. "Feature Match" is a 90-second timed test. Feature Match is a focus and processing task that requires surveying an increasingly difficult array of information and rapidly assessing the correct response while holding previously processed and detailed information in attention. 18 days
Primary Changes in scores on a cognitive assessment "Grammatical Reasoning". [Time Frame: Baseline to Day 3 of each test cycle] Participants will independently complete a cognitive assessment battery at home on their computer or tablet. "Grammatical Reasoning" is a 90-second timed test. Grammatical Reasoning is a deductive reasoning task that requires quickly interpreting phrases and making logical conclusions from understanding. Variation between text and shapes on screen requires holding key information in short-term memory to properly complete the task, leveraging the same parts of the brain that enable an individual to remain focused between varied stimuli. 18 days
Primary Changes in scores on a cognitive assessment "Digit Span". [Time Frame: Baseline to Day 3 of each test cycle] Participants will independently complete a cognitive assessment battery at home on their computer or tablet. "Digit Span is a 3-4 minute performance based test. Increasing in length after each successful attempt, Digit Span requires users to focus on displayed numbers, hold them in short-term memory, and repeat them back correctly, thereby showing cognitive flexibility and the brain's ability to perform memory and attention-related tasks without error. 18 days
Secondary Occurence of the side effects of caffeine withdrawal. [Baseline to Endline] Decrease in symptoms of caffeine withdrawal including jitters, fatigue, drowsiness, irritability, "brain fog", and low alertness. This will be reported via participant-reported questionnaires. Incidence and severity of side effects will be reported using a Likert scale (0-5 point scale) with 0=least severe and 5=most severe. 18 days
See also
  Status Clinical Trial Phase
Completed NCT06048640 - Effects of Dynamine Ingestion on Various Indices of Sustained Energy N/A
Active, not recruiting NCT06074627 - Radicle Energy2: A Study of Health and Wellness Products on Fatigue and Other Health Outcomes N/A
Active, not recruiting NCT06082778 - ZOE's Ferment Experiment N/A
Completed NCT06104891 - Radicle Recharge: A Study of Health and Wellness Products on Energy Levels and Other Health Outcomes N/A
Completed NCT00942695 - Energy Value of Macronutrients From Pistachio Nuts and Mechanisms of Nutrient Action N/A
Completed NCT06019858 - A Clinical Trial to Assess the Effects of a Vitamin Shot on Energy Levels N/A
Completed NCT01625624 - Evaluating the Effects of Food Products on Energy and Performance N/A
Completed NCT03529240 - Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption N/A
Active, not recruiting NCT06023082 - A Single-Group Study to Examine the Efficacy of a Gut Health Supplement to Increase Metabolism, Improve Gut Health, and Support Weight Management N/A
Completed NCT04787718 - Almond for Physical Performance N/A
Completed NCT01544816 - Evaluating the Effects of Snack Products on Energy N/A
Active, not recruiting NCT06201689 - Radicle Energy 24: A Study of Health and Wellness Products on Fatigue and Related Health Outcomes N/A
Completed NCT01264406 - The Comparison of Energy in Take and Body Weight EXERCISE N/A
Completed NCT05502328 - Radicle Energy: A Study of Cannabinoids on Energy and Other Health Outcomes N/A